Evidence map›Paper›PMID 34994382›Full record

ArticleBiology open2022

Loss of p19Arf promotes fibroblast survival during leucine deprivation.

Kerry C Roby, Allyson Lieberman, Bang-Jin Kim, Nicole Zaragoza Rodríguez, Jessica M Posimo, Tiffany Tsang, Ioannis I Verginadis, Ellen Puré, Donita C Brady, Constantinos Koumenis and 1 more

Open access · goldAbstract read
In one paragraph

Article in Biology open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Kerry C RobyDepartment of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Allyson LiebermanDepartment of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Bang-Jin KimDepartment of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Nicole Zaragoza RodríguezDepartment of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Jessica M PosimoDepartment of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Tiffany TsangDepartment of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Ioannis I VerginadisDepartment of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Ellen PuréDepartment of Biomedical Sciences, University of Pennsylvania, School of Veterinary Medicine, Philadelphia, PA 19104, USA.
Donita C BradyDepartment of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Constantinos KoumenisDepartment of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Sandra RyeomDepartment of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0002-9869-4455
University of Pennsylvania · USCancer Research Institute · US

Funding

UPR, interferon signaling and tumorigenesisP01CA165997 · NCI · UNIVERSITY OF PENNSYLVANIA · PI KOUMENIS, CONSTANTINOS · 2013 to 2023
$10.9M
Project 3 - Immune analysis of clinical trial samplesP01CA217805 · NCI · UNIVERSITY OF PENNSYLVANIA · PI HWANG, WEI-TING · 2018 to 2022
$10.4M
Negative Regulation of VEGF-Mediated AngiogenesisR01CA118374 · NCI · UNIVERSITY OF PENNSYLVANIA · PI RYEOM, SANDRA · 2009 to 2019
$3.4M
The role of endothelial cells in the formation of early metastatic niches in the lungR56CA118374 · NCI · UNIVERSITY OF PENNSYLVANIA · PI RYEOM, SANDRA · 2021 to 2021
$122k
Investigating paradoxical YAP activation as an emergent limitation to Cu chelation therapy in BRAF V600E-driven melanomaF31CA243294 · NCI · UNIVERSITY OF PENNSYLVANIA · PI TSANG, TIFFANY · 2019 to 2020
$67k
NCI NIH HHS F31 CA243294NCI NIH HHS P01 CA165997NCI NIH HHS P01 CA217805NCI NIH HHS R01 CA118374NCI NIH HHS R56 CA118374
6 · The paper itself

Abstract

Fibroblasts are quiescent and tumor suppressive in nature but become activated in wound healing and cancer. The response of fibroblasts to cellular stress has not been extensively investigated, however the p53 tumor suppressor has been shown to be activated in fibroblasts during nutrient deprivation. Since the p19 Alternative reading frame (p19Arf) tumor suppressor is a key regulator of p53 activation during oncogenic stress, we investigated the role of p19Arf in fibroblasts during nutrient deprivation. Here, we show that prolonged leucine deprivation results in increased expression and nuclear localization of p19Arf, triggering apoptosis in primary murine adult lung fibroblasts (ALFs). In contrast, the absence of p19Arf during long-term leucine deprivation resulted in increased ALF proliferation, migration and survival through upregulation of the Integrated Stress Response pathway and increased autophagic flux. Our data implicates a new role for p19Arf in response to nutrient deprivation. This article has an associated First Person interview with the first author of the paper.

Indexed as

Tumor Suppressor Protein p14ARFTumor Suppressor Protein p53AnimalsCyclin-Dependent Kinase Inhibitor p16FibroblastsHumansLeucineMiceCyclin-Dependent Kinase Inhibitor p16LeucineTumor Suppressor Protein p14ARFTumor Suppressor Protein p53AutophagyFibroblastIntegrated stress responseLeucine deprivationP19Arf

Identifiers

PMID34994382
PMCPMC8864297
OpenAlexW4205752556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.